Antiviral targets of a chromene derivative from Sargassum micracanthum in the replication of human cytomegalovirus

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 9, 2006, Pages 1843-1847

  Hayashi, Kyoko ^a   Mori, Jun ^b   Saito, Haruo ^b   Hayashi, Toshimitsu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Lead Chemical Co Ltd   (Japan)

Author keywords

Anti human cytomegalovirus action; Binding inhibition; Ganciclovir; Synergistic interaction; Virucidal activity

Indexed keywords

CHROMENE DERIVATIVE; GANCICLOVIR;

ARTICLE; CYTOMEGALOVIRUS; DNA SYNTHESIS; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; SARGASSUM; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BENZOPYRANS; CYTOMEGALOVIRUS; DRUG SYNERGISM; GANCICLOVIR; HUMANS; SARGASSUM; VIRION; VIRUS REPLICATION;

EID: 33748350722     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1843     Document Type: Article

References (30)

1. Morita M., Morishima T., Yamazaki T., Chiba S., Kawana T., Acta Paediatr. Jpn., 40, 432-436 (1998).
2. Mocarski E. S., Courcelle C. T., "Cytomegaloviruses and Their Replication, Field Virology," Chap. 76, ed. by Knipe D. M., Howley P. M., Lippincott Williams & Wilkins, Philadelphia, 2001, pp. 2629-2674.
3. De Clercq E., J. Antimicrob. Chemother., 51, 1079-1083 (2003).
4. Martinez A. A., Gil C. C., Perez C., Med. Res. Rev., 21, 227-244 (2001).
5. Faulds D., Heal R. C., Drugs, 39, 597-638 (1990).
6. Wagataff A. J., Bryson H. M., Drugs, 48, 199-226 (1994).
7. Lea A. P., Bryson H. M., Drugs, 52, 225-230 (1996).
8. Perry C. M., Barman-Balfour J. A., Drugs, 57, 375-380 (1999).
9. Curran M., Noble S., Drugs, 61, 1145-1150 (2001).
10. Rasmussen L., Chen P. T., Mullenax J. G., Merigan T. C., Antimicrob. Agents Chemother., 26, 441-445 (1984).
11. Rush J., Mills J., J. Med. Virol., 21, 269-276 (1987).
12. Manischewitz J. F., Quinnan G. V., Jr., Lane H. C., Wittek A. E., Antimicrob. Agents Chemother., 34, 373-375 (1990).
13. Smee D. F., Bartlett M. L., Alaghamandan H. A., Jones M. M., Antiviral Res., 13, 1-10 (1990).
14. Hamzeh F. M., Spector T., Lietman P. S., Antimicrob. Agents Chemother., 37, 602-604 (1993).
15. Iwashima M., Mori J., Ting X., Matsunaga T., Hayashi K., Shinoda D., Saito H., Sankawa U., Hayashi T., Biol. Pharm. Bull., 28, 374-377 (2005).
16. Kashman Y., Gustafson K. R., Fuller R. W., Cardellina J. H., II, McMahon J. B., Currens M. J., Buckheit R. W., Jr., Hughes S. H., Cragg G. M., Boyd M. R., J. Med. Chem., 35, 2735-2743 (1992).
17. Flavin M. T., Rizzo J. D., Khilerich A., Kucherenko A., Sheinkman A. K., Vilaychack V., Lin L., Chen L., Greenwood E. M., Pengsuparp T., Pezzuto J. M., Hughes S. H., Flavin T. M., Gibulski M., Boulanger W. A., Shone R. L., Xu Z.-Q., J. Med. Chem., 39, 1303-1313 (1996).
18. Hayashi K., Hayashi T., Otsuka H., Takeda Y., J. Antimicrob. Chemother., 39, 821-824 (1997).
19. Elion G. B., Singer S., Hitchings G. H., J. Biol. Chem., 208, 477-488 (1954).
20. Penfold M. E., Mocarski E. S., Virology, 239, 46-61 (1997).
21. Damonte E., Neyts J., Pujol C. A., Snoeck R., Andrei G., Ikeda S., Witvrouw M., Reymen D., Haines H., Matulewicz M. C., Cerezo A., Coto C. E., De Clercq E., Biochem. Pharmacol., 47, 2187-2192 (1994).
22. Hayashi T., Hayashi K., Maeda M., Kojima I., J. Nat. Prod., 59, 83-87 (1996).
23. Hoshino T., Hayashi T., Hayashi K., Hamada J., Lee J.-B., Biol. Pharm. Bull., 21, 730-734 (1998).
24. Lee J.-B., Hayashi K., Hayashi T., Sankawa U., Maeda M., Planta Med., 65, 439-441 (1999).
25. Feldman S. C., Reynaldi S., Stortz C. A., Cerezo A. S., Damont E. B., Phytomedicine, 6, 335-340 (1999).
26. Stinski M. F., J. Virol., 26, 686-701 (1978).
27. Adlish J. D., Lahijani R. S., St. Jeor S. C., Virology., 176, 337-345 (1990).
28. Taylor H. P., Cooper N. R., J. Virol., 64, 2484-2490 (1990).
29. Compton T., Nowlin D. M., Cooper N. R., Virology, 193, 834-841 (1993).
30. Compton T., Nepomuceno R. R., Nowlin D. M., Virology, 191, 387-395 (1992).